Corrigendum to "Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol" [Toxicology and Applied Pharmacology, 378 (2019) 114619].
Toxicol Appl Pharmacol
; 380: 114701, 2019 Oct 01.
Article
en En
| MEDLINE
| ID: mdl-31398422
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Año:
2019
Tipo del documento:
Article